Mint Tower Capital Management B.V. Buys Shares of 150,000 Kenvue Inc. $KVUE

Key Points

• Mint Tower Capital Management disclosed a new fourth-quarter stake in Kenvue, buying 150,000 shares valued at about $2.59 million.
• Kenvue’s stock was trading around $18.08, and the company reported better-than-expected Q1 earnings with EPS of $0.32 versus the $0.27 estimate and revenue of $3.91 billion.
• Analyst sentiment remains cautious: the stock’s average rating is Hold with an average price target of $19.33, even as Kenvue pays a quarterly dividend yielding about 4.6%.

Mint Tower Capital Management B.V. bought a new stake in shares of Kenvue Inc. (NYSE:KVUE - Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund bought 150,000 shares of the company's stock, valued at approximately $2,588,000.

A number of other hedge funds have also added to or reduced their stakes in the stock. Aviva PLC grew its stake in shares of Kenvue by 2.8% during the 4th quarter. Aviva PLC now owns 1,535,228 shares of the company's stock valued at $26,483,000 after purchasing an additional 41,501 shares during the period. Athos Capital Ltd grew its stake in shares of Kenvue by 38.3% during the 4th quarter. Athos Capital Ltd now owns 3,457,749 shares of the company's stock valued at $59,646,000 after purchasing an additional 957,749 shares during the period. Equity Investment Corp grew its stake in shares of Kenvue by 32.1% during the 4th quarter. Equity Investment Corp now owns 6,820,350 shares of the company's stock valued at $117,651,000 after purchasing an additional 1,655,417 shares during the period. Sustainable Insight Capital Management LLC bought a new stake in shares of Kenvue during the 4th quarter valued at about $326,000. Finally, Kovack Advisors Inc. bought a new stake in shares of Kenvue during the 4th quarter valued at about $304,000. 97.64% of the stock is currently owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other Kenvue news, General Counsel Matthew Orlando sold 38,491 shares of the company's stock in a transaction that occurred on Friday, May 8th. The stock was sold at an average price of $17.66, for a total value of $679,751.06. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 1.59% of the stock is owned by insiders.

Analyst Ratings Changes

Several brokerages recently issued reports on KVUE. Barclays cut their target price on shares of Kenvue from $19.00 to $18.00 and set an "equal weight" rating for the company in a research report on Tuesday, April 14th. Zacks Research upgraded shares of Kenvue from a "hold" rating to a "strong-buy" rating in a research report on Friday, May 8th. Citigroup cut their price objective on shares of Kenvue from $20.00 to $19.00 and set a "neutral" rating for the company in a research report on Wednesday, April 15th. UBS Group cut their price objective on shares of Kenvue from $19.00 to $18.00 and set a "neutral" rating for the company in a research report on Tuesday, April 7th. Finally, Weiss Ratings downgraded shares of Kenvue from a "hold (c)" rating to a "hold (c-)" rating in a research report on Friday, May 29th. One equities research analyst has rated the stock with a Strong Buy rating, three have given a Buy rating and twelve have issued a Hold rating to the company's stock. According to data from MarketBeat, the company currently has an average rating of "Hold" and an average price target of $19.33.

Kenvue Trading Up 0.1%

Shares of Kenvue stock opened at $18.08 on Friday. The company has a market capitalization of $34.70 billion, a P/E ratio of 21.26, a P/E/G ratio of 1.37 and a beta of 0.54. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.70 and a current ratio of 0.98. The company has a fifty day moving average of $17.41 and a 200 day moving average of $17.53. Kenvue Inc. has a fifty-two week low of $14.02 and a fifty-two week high of $22.87.

Kenvue (NYSE:KVUE - Get Free Report) last issued its earnings results on Thursday, May 7th. The company reported $0.32 earnings per share for the quarter, topping the consensus estimate of $0.27 by $0.05. The company had revenue of $3.91 billion during the quarter, compared to the consensus estimate of $3.84 billion. Kenvue had a net margin of 10.61% and a return on equity of 20.81%. Kenvue's quarterly revenue was up 4.5% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.24 EPS. On average, sell-side analysts anticipate that Kenvue Inc. will post 1.16 earnings per share for the current fiscal year.

Kenvue Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Wednesday, May 27th. Shareholders of record on Wednesday, May 13th were paid a $0.2075 dividend. This represents a $0.83 annualized dividend and a yield of 4.6%. The ex-dividend date was Wednesday, May 13th. Kenvue's dividend payout ratio is presently 97.65%.

Kenvue Company Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.

Want to see what other hedge funds are holding KVUE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Kenvue Inc. (NYSE:KVUE - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.